In a stunning new development Illumina, a silicon valley biotech company, is launching a new venture to perfect a blood…
The impact of delay on the prognosis of newly diagnosed cancer is hotly debated among participants in malpractice litigation. Much…
The big news in December 2015 for breast cancer is that adding a bone strengthening agent to post-operative therapy reduces…
Does the volume of mammography done at an institution have an effect on the quality of the work done? A…
As reported in a recent issue of the Journal of the National Cancer Institute Healy and colleagues from the University…